Monthly Archives: May 2021

Abivax reports positive phase 2b results of ABX464 in ulcerative colitis

    Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com         SPECIAL REPORT #21.14     Abivax reports positive phase 2b results of ABX464 in ulcerative colitis     In the evening of May 24, Abivax, a Paris-based biotechnology company, released remarkable results of ABX464 in a randomized, double-blind phase 2b […]

read more

Top Pharma’s R&D Profile in Q1 2021

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #21.13     Top Pharma’s R&D Profile in Q1 2021     In the May issue of MedNous (www.mednous.com), Victoria English, the journal editor, publishes an article, which comprehensively extends our Special Report #21. 9 of April 6, 2021 and […]

read more

The Top 20 Drugs and Vaccines by Worldwide Sales in 2020

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #21.12     The Top 20 Drugs and Vaccines by Worldwide Sales in 2020     Every year, shortly after the first quarter results, Fierce Pharma, with the assistance of Evaluate Pharma, issues the list of the Top 20 drugs […]

read more

Focus on some European Biotechnology Companies

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #21.11     Covid 19-vaccine spending and a focus on some European Biotechnology Companies     We are starting this new week and month with a short roundup of the COVID-19 business and with an interesting focus on some European […]

read more